Cell banking and Viral seed stocks
Utilising our strong track record in this area, we manufacture and store on-site master/working cell banks and viral seed stocks to support client projects on their journey through the three clinical trial phases to commercial supply.
FinVector’s Research and Development department is at the forefront for process development activities in advanced therapies.
Platform Process Development/Scale Up
During FinVector's two decades in operation, we have developed a range of adherent and suspension-based platform processes for viral vectors.
Assay Development and Analytical Testing
The ethos of FinVector's experienced analytical development team is to work with clients through all stages of custom assay development.
FinVector Aseptic Filling Capability
One of the key services FinVector offers is the aseptic filling of liquid investigational medicinal products (IMPs), or commercial products.
FinVector can provide short-term and long-term stability studies according to ICH guidelines to monitor product integrity over time and at multiple storage conditions.
Viral Vectors (including Adeno, AAV, Lenti)
FinVector’s unique facilities, matched with the extensive experience of our scientific team, enables us to work with a broad range of viral vectors, especially Adenoviruses (recombinant, oncolytic), Adeno Associated Virus (AAV) and Lentivirus.